Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 25, Issue 2, 2000, Pages 179-184

  Lee, J H ^a,c   Lee, K H ^a   Kim, S ^a   Lee, J S ^a   Kim, S H ^a   Kwon, S W ^b   Kim, W K ^a  

^a Sungkyunkwan University   (South Korea)

^b University of Ulsan   (South Korea)

^c Asan Medical Center   (South Korea)

Author keywords

ABO incompatible BMT; Anti A isoagglutinin; PRCA

Indexed keywords

AGGLUTININ;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RETICULOCYTE; RISK FACTOR;

EID: 0033951894     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702121     Document Type: Article

References (23)

1. Braine HG, Sensenbrenner LL, Wright SK et al. Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion. Blood 1982; 60: 420-425.
2. Reviron J, Schenmetzler C, Bussel A et al. Obstacle to red cell engraftment due to major ABO incompatibility in allogeneic bone marrow transplants (BMT): quantitative and kinetic aspects in 58 BMTs. Transplant Proc 1987; 19: 4618-4622.
3. Jin NR, Hill R, Segal G et al. Preparation of red-blood-cell-depleted marrow for ABO-incompatible marrow transplantation by density-gradient separation using the IBM 2991 blood cell processor. Exp Hematol 1987; 15: 93-98.
4. Nussbaumer W, Schwaighofer H, Gratwohl A et al. Transfusion of donor-type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibility. Transfusion 1995; 35: 592-595.
5. Buckner CD, Clift RA, Sanders JE et al. ABO-incompatible marrow transplants. Transplantation 1978; 26: 233-238.
6. Bensinger WI, Buckner CD, Thomas ED, Clift RA. ABO-incompatible transplants. Transplantation 1982; 33: 427-429.
7. Sniecinski IJ, Petz LD, Oien L, Blume KG. Immunohematologic problems arising from ABO incompatible bone marrow transplantation. Transplant Proc 1987; 19: 4609-4611.
8. Gmür JP, Burger J, Schaffner A et al. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 1990; 75: 290-295.
9. Klumpp TR. Immunohematologic complications of bone marrow transplantation. Bone Marrow Transplant 1991; 8: 159-170.
10. Bär BMAM, Van Dijk BA, Schattenberg A et al. Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow. Bone Marrow Transplant 1995; 16: 793-799.
11. Lopez, A, de la Rubia J, Arriaga F et al. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant. Transfusion 1998; 38: 247-251.
12. Mehta J, Powles R, Singhal S et al. Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility. Bone Marrow Transplant 1996; 18: 151-156.
13. Sieff C, Bicknell D, Caine G et al. Changes in cell surface antigen expression during hemopoietic differentiation. Blood 1982; 60: 703-713.
14. Sahovic EA, Flick J, Graham CD, Stuart RK. Case report: isoimmune inhibition of erythropoiesis following ABO-incomputible bone marrow transplantation. Am J Med Sci 1991: 302: 369-373.
15. Wernet D, Mayer G. Isoagglutinins following ABO-incompatible bone marrow transplantation. Vox Sang 1992; 62: 176-179.
16. Heyll A, Aul C, Runde V et al. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin. Blood 1991; 77: 906.
17. Labar B, Bogdanić V, Nemet D et al. Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant. Bone Marrow Transplant 1992; 10: 471-472.
18. Ohashi K, Akiyama H, Takamoto S et al. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplant 1994; 13: 335-336.
19. Cockerill KJ, Lyding J, Zander AR. Red cell aplasia due to host type isohemagglutinins with exuberant red cell progenitor production of donor type in an ABO-mismatched allogeneic bone marrow transplant recipient. Eur J Haematol 1989; 43: 195-200.
20. Or R, Naparstek E, Mani N, Slavin S. Treatment of pure red-cell aplasia following major ABO-mismatched T-cell-depleted bone marrow transplantation. Two case reports with successful response to plasmapheresis. Transplant Int 1991; 4: 99-102.
21. Hows JM, Chipping PM, Palmer S, Gordon-Smith EC. Regeneration of peripheral blood cells following ABO incompatible allogeneic bone marrow transplantation for severe aplastic anemia. Br J Haematol 1983; 53: 145-151.
22. Hows J, Beddow K, Gordon-Smith E et al. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood 1986; 67: 177-181.
23. Sniecinski IJ, Oien L, Petz LD, Blume KG. Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation 1988; 45: 530-534.